Mpox Immune response elicited by MVA-BN vaccine over 12 months of follow-up
Open Access
- 4 October 2024
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 89 (6) , 106309
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyeClinicalMedicine, 2024
- Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyThe Lancet Infectious Diseases, 2023
- Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United StatesNew England Journal of Medicine, 2023
- Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational studyThe Lancet Infectious Diseases, 2023
- Real-world effectiveness of a single dose of mpox vaccine in malesNature Medicine, 2023
- Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccinationJournal of Infection, 2022
- Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individualsNature Medicine, 2022